The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
2
|
H01 | Pituitary and hypothalamic hormones and analogues | |
3
|
H01C | Hypothalamic hormones | |
4
|
H01CB | Somatostatin and analogues | |
5
|
H01CB06 |
| Active Ingredient |
|---|
|
Similar to the natural hormone somatostatin, paltusotine suppresses growth hormone (GH) and insulin-like growth factor-1 (IGF-1) secretion. Paltusotine exerts its pharmacological activity via selective agonism (>4000-fold) at somatostatin receptor 2 (SSTR2) and exhibits little or no affinity for other SST receptor subtypes. |
| Document | Type | Information Source | |
|---|---|---|---|
| PALSONIFY Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |